Physician profile
Steven M Madey
NPI 1083719793
$1,183,681.01
in general payments reported to CMS, 2019-2025
13 companies · $147K in 2025
The $147K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204K · 2020: $209K · 2021: $142K · 2022: $157K · 2023: $172K · 2024: $153K · 2025: $147K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $471K · Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $470,677.88 |
| Food and Beverage | $708.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,169,113.77 | 2019-2025 | Matrixrib |
| Zimmer Biomet Holdings, INC. | $13,388.28 | 2019-2022 | |
| Stryker Corporation | $296.75 | 2020 | |
| Left Coast Surgical INC | $211.20 | 2025 | |
| Next Science LLC | $204.48 | 2023 | Xperience, Blastx, Surgx |
| Checkpoint Surgical, INC | $166.10 | 2025 | Checkpoint Stimulators |
| Encore Medical, Lp | $98.00 | 2024 | Djo Surgical |
| Steelhead Surgical INC | $63.83 | 2019 | |
| Depuy Synthes Sales INC. | $58.99 | 2022-2024 | Motoband |
| Djo, LLC | $33.12 | 2021 | |
| Baxter Healthcare | $18.97 | 2024 | Floseal |
| Smith+Nephew, INC. | $15.50 | 2022 | |
| Orthofix Medical, INC. | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Madey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.